Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)

被引：0
|
作者：
Wuyts, Wim A. [1 ]
Maher, Toby M. [2 ]
Wijsenbeek, Marlies [3 ]
Koschel, Dirk [4 ]
Martinez, Fernando J. [5 ]
Stansen, Wibke [6 ]
Stowasser, Susanne [7 ]
Richeldi, Luca [8 ]
机构：
[1] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Univ Med Ctr, Dept Resp Med, Erasmus MC, Rotterdam, Netherlands
[4] Fachkrankenhaus Coswig, Coswig, Germany
[5] Weill Cornell Med, New York, NY USA
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli IRCCS, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2875
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Predicted Versus Observed Mortality in Clinical Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (IPF)
    Ryerson, C. J.
    Wijsenbeek, M.
    Bonella, F.
    Spagnolo, P.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [12] POOLED ANALYSIS OF MORTALITY DATA FROM THE TOMORROW AND INPULSIS TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Corte, T.
    Richeldi, L.
    Kirsten, A.
    Roman, J.
    Le Maulf, F.
    Hallmann, C.
    Stowasser, S.
    Lasky, J.
    RESPIROLOGY, 2015, 20 : 87 - 87
  • [13] Nintedanib for Idiopathic Pulmonary Fibrosis
    Tepede, Abisola
    Yogaratnam, Dinesh
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) : 199 - 206
  • [14] NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS
    Woodcock, H. V.
    Maher, T. M.
    DRUGS OF TODAY, 2015, 51 (06) : 345 - 356
  • [15] Nintedanib in idiopathic pulmonary fibrosis
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : E108 - E108
  • [16] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Kawada, Tomoyuki
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1274 - +
  • [17] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [18] Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain
    Valenzuela, Claudia
    Molina, Maria Molina
    Portal, Jose Antonio Rodriguez
    Ortiz, Romero
    Cano, Esteban
    Nieto, Maria Jesus Rodriguez
    Laporta, Rosalia
    Ancochea, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [19] Search for Host Factors That Predict the Therapeutic Effect of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF)
    Arai, N.
    Matsuyama, M.
    Nakajima, M.
    Yazaki, K.
    Nonaka, M.
    Sakai, C.
    Matsumura, S.
    Numata, T.
    Yanai, H.
    Yamamoto, Y.
    Akatsu, Y.
    Iijima, H.
    Masuko, H.
    Matsuno, Y.
    Morishima, Y.
    Endo, T.
    Saito, T.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [20] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
12345